Donepezil not checked

Eisai · E2022 Tape · E2020

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 1 trial completes
Trials
4 active
14 in total · 4 in the EU
Targets
—
None known yet

What this is

How it works
Cholinesterase Inhibitor FDA class
Tested for
Alzheimers Disease
Main trialPhase 1
“The primary purpose of this study is to evaluate proof of mechanism (POM) and long-term safety and tolerability of E2511 in participants with Early AD. The study consists of 2 parts. In Part A, participants will be randomly assigned to receive either E2511 or donepezil. In Part B, participants will receive E2511 only. Once Part A and Part B participants complete the Core Trial (which includes Pretreatment and Treatment phases) they will have the option to enter the Extension Phase where they will receive E2511 for 18 months.”In the company’s words, NCT07768592 on ClinicalTrials.gov
Other names
E2022 Tape · Aricept · E2020

Other drugs for Alzheimers Disease

All 91 drugs for Alzheimers Disease

Copies tested against it3

Other companies’ versions, mostly cheaper copies for when the patent ends

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials14

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting 6 May 2030 A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)
Phase 4Completed 31 Jul 2006 Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Phase 4Completed 15 Aug 2008 Neural Correlates In Mild Alzheimer's Disease
Phase 4Completed 31 Aug 2008 The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Phase 3Completed 26 May 2009 Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
Phase 3Completed 1 Apr 2010 Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease
Phase 3Completed Mar 2013 A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Phase 2Completed 5 Sep 2008 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Phase 2Terminated 13 Nov 2008 Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
Phase 1Completed Apr 2013 A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males
Phase 2Authorised not given Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease.
Phase 2Authorised not given Treatment with acetylcholine esterase inhibitors in anorexia nervosa : a multicenter double-blind randomised controlled trial versus placebo
Phase 2Ended not given Impact of CHOlinergic Stimulation on COgnitive and MOtor Functions and Brain Activity in Elderly Volunteers (CHOCOMO) - a randomised, placebo-controlled trial
Phase 4Authorised not given CHOLINE-2 - Donepezil Versus Non-drug Treatment in Alzheimer's Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Donepezil

Following is part of Solo: you see every change to Donepezil the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in